| Name | 2-(hydroxymethylidene)-1,4-dihydropyrido[2,3-b]pyrazin-3-one |
|---|
| Molecular Formula | C8H7N3O2 |
|---|---|
| Molecular Weight | 177.16000 |
| Exact Mass | 177.05400 |
| PSA | 82.03000 |
| LogP | 0.24060 |
|
~41%
177944-77-3 |
| Literature: State of Oregon, Acting by and through the Oregon State Board of Higher Education, Acting for and on Behalf of the Oregon Health Sciences University and the University of Oregon; Acea Pharmaceuticals, Inc.; The Regents of the University of California Patent: US5597922 A1, 1997 ; US 5597922 A |
|
~0%
177944-77-3 |
| Literature: State of Oregon, Acting by and through the Oregon State Board of Higher Education, Acting for and on Behalf of the Oregon Health Sciences University and the University of Oregon; Acea Pharmaceuticals, Inc.; The Regents of the University of California Patent: US5597922 A1, 1997 ; US 5597922 A |